Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07VYX
|
|||
Former ID |
DNC007295
|
|||
Drug Name |
4-((+/-)-(1H-imidazol-1-yl)-(E)-methylretinoate
|
|||
Synonyms |
CHEMBL224828; 4-((+/-)-(1H-imidazol-1-yl)-(E)-methylretinoate; BDBM50158415; 4-(1-Imidazolyl)retinoic acid methyl ester
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C24H32N2O2
|
|||
Canonical SMILES |
CC1=C(C(CCC1N2C=CN=C2)(C)C)C=CC(=CC=CC(=CC(=O)OC)C)C
|
|||
InChI |
1S/C24H32N2O2/c1-18(8-7-9-19(2)16-23(27)28-6)10-11-21-20(3)22(12-13-24(21,4)5)26-15-14-25-17-26/h7-11,14-17,22H,12-13H2,1-6H3/b9-7+,11-10+,18-8+,19-16+
|
|||
InChIKey |
LEOKNFOQHCUMCU-PFLBVIONSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Cytochrome P450 26 (CYP26A1) | Target Info | Inhibitor | [1] |
KEGG Pathway | Retinol metabolism | |||
Metabolic pathways | ||||
Pathwhiz Pathway | Retinol Metabolism | |||
WikiPathways | Vitamin A and Carotenoid Metabolism | |||
Metapathway biotransformation | ||||
Oxidation by Cytochrome P450 | ||||
Nuclear Receptors in Lipid Metabolism and Toxicity | ||||
Adipogenesis | ||||
Phase 1 - Functionalization of compounds |
References | Top | |||
---|---|---|---|---|
REF 1 | Novel retinoic acid metabolism blocking agents endowed with multiple biological activities are efficient growth inhibitors of human breast and pros... J Med Chem. 2004 Dec 30;47(27):6716-29. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.